Compliance with biopsy recommendations of a prostate cancer risk calculator

BJU International

Volumn 109, Issue 10, 2012, Pages 1480-1488

  Van Vugt, Heidi A ^a,b   Roobol, Monique J ^a   Busstra, Martijn ^a   Kil, Paul ^c   Oomens, Eric H ^d   De Jong, Igle J ^e   Bangma, Chris H ^a   Steyerberg, Ewout W ^b   Korfage, Ida ^b  

^a Department of Urology ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CPRLab   (Netherlands)

^d AMPHIA HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

compliance; prediction rule; prostate cancer; PSA testing; risk calculator; risk communication

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DECISIONAL CONFLICT SCALE; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORIAL ANXIETY SCALE FOR PROSTATE CANCER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SHORT FORM 12; STATE TRAIT ANXIETY INVENTORY; TRANSRECTAL ULTRASONOGRAPHY; UROLOGIST;

AGED; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; NETHERLANDS; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84860342391     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10611.x     Document Type: Article

References (31)

1. Roobol MJ, Steyerberg EW, Kranse R, et al,. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010; 57: 79-85
2. Vickers A, Cronin A, Roobol M, et al,. Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. J Clin Oncol 2010; 28: 2493-8
3. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW,. An updated catalog of prostate cancer predictive tools. Cancer 2008; 113: 3075-99
4. Ross PL, Gerigk C, Gonen M, et al,. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 2002; 20: 82-8
5. Vlaev I, Chater N,. Game relativity: how context influences strategic decision making. J Exp Psychol Learn Mem Cogn 2006; 32: 131-49
6. Elstein AS,. Heuristics and biases: selected errors in clinical reasoning. Acad Med 1999; 74: 791-4
7. Kranse R, Roobol M, Schroder FH,. A graphical device to represent the outcomes of a logistic regression analysis. Prostate 2008; 68: 1674-80
8. van Vugt HA, Roobol MJ, Kranse R, et al,. Prediction of prostate cancer in unscreened men: external validation of a risk calculator. Eur J Cancer 2010; 47: 903-9
9. Reilly BM, Evans AT,. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Int Med 2006; 144: 201-9
10. Toll DB, Janssen KJ, Vergouwe Y, Moons KG,. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol 2008; 61: 1085-94
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83
12. Ware J Jr, Kosinski M, Keller SD,. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33
13. van der Bij AK, de Weerd S, Cikot RJ, Steegers EA, Braspenning JC,. Validation of the Dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Community Genet 2003; 6: 84-7
14. Spielberger CD, Vagg PR,. Psychometric properties of the STAI: a reply to Ramanaiah, Franzen, and Schill. J Pers Assess 1984; 48: 95-7
15. van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot ML,. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the Memorial Anxiety Scale for Prostate Cancer. Qual Life Res 2009; 18: 1061-6
16. Koedoot N, Molenaar S, Oosterveld P, et al,. The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns 2001; 45: 187-93
17. OHD C. User Manual-Decisional Conflict Scale(S). Ottawa: Ottawa Health Decision Centre at the Ottawa Health Reseach Institute, University of Ottawa, 2006
18. Marteau TM, Dormandy E, Michie S,. A measure of informed choice. Health Expect 2001; 4: 99-108
19. van Vugt HA, Roobol MJ, Venderbos LD, et al,. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator. Eur J Cancer 2010; 46: 669-77
20. Connor MNP,. Predicting Health Behaviour. Buckingham: Open University Press, 1996
21. Schroder FH, Hugosson J, Roobol MJ, et al,. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
22. Roobol MJ, Kerkhof M, Schroder FH, et al,. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2009; 56: 584-91
23. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS,. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA 2000; 284: 79-84
24. Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schroder FH,. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 2007; 177: 107-12
25. Boevee SJ, Venderbos LD, Tammela TL, et al,. Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer. Eur J Cancer 2010; 46: 3082-9
26. Brehaut JC, Stiell IG, Graham ID,. Will a new clinical decision rule be widely used? The case of the Canadian C-spine rule. Acad Emerg Med 2006; 13: 413-20
27. Edwards A, Unigwe S, Elwyn G, Hood K,. Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 2003; 327: 703-9
28. Cantor SB, Volk RJ, Cass AR, Gilani J, Spann SJ,. Psychological benefits of prostate cancer screening: the role of reassurance. Health Expect 2002; 5: 104-13
29. Epstein RM, Alper BS, Quill TE,. Communicating evidence for participatory decision making. JAMA 2004; 291: 2359-66
30. Stiell IG, McKnight RD, Greenberg GH, et al,. Implementation of the Ottawa ankle rules. JAMA 1994; 271: 827-32
31. Michie S, Lester K, Pinto J, Marteau TM,. Communicating risk information in genetic counseling: an observational study. Health Educ Behav 2005; 32: 589-98